APRINOIA Therapeutics (APRI) – Momentum Movers
-
Apricus Biosciences (APRI) Up 27% in Pre-Market Trading Following Sale of Ex-US Vitaros Assets
-
Apricus Biosciences (APRI) Ramps on Erectile Dysfunction Approval in Mexico
-
-
-
-
-
-
Back to APRI Stock Lookup